ICU Medical EBITDA Margin 2010-2024 | ICUI
Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for ICU Medical (ICUI) over the last 10 years. The current EBITDA margin for ICU Medical as of December 31, 2024 is .
| ICU Medical EBITDA Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM EBITDA | EBITDA Margin |
| 2024-12-31 | $2.38B | $0.27B | 11.29% |
| 2024-09-30 | $2.34B | $0.22B | 9.57% |
| 2024-06-30 | $2.30B | $0.24B | 10.46% |
| 2024-03-31 | $2.26B | $0.24B | 10.59% |
| 2023-12-31 | $2.26B | $0.26B | 11.47% |
| 2023-09-30 | $2.25B | $0.27B | 12.18% |
| 2023-06-30 | $2.29B | $0.25B | 10.94% |
| 2023-03-31 | $2.31B | $0.26B | 11.45% |
| 2022-12-31 | $2.28B | $0.23B | 9.91% |
| 2022-09-30 | $2.04B | $0.21B | 10.33% |
| 2022-06-30 | $1.78B | $0.21B | 11.90% |
| 2022-03-31 | $1.54B | $0.19B | 12.32% |
| 2021-12-31 | $1.32B | $0.21B | 16.25% |
| 2021-09-30 | $1.30B | $0.22B | 16.67% |
| 2021-06-30 | $1.28B | $0.20B | 15.48% |
| 2021-03-31 | $1.26B | $0.19B | 14.76% |
| 2020-12-31 | $1.27B | $0.18B | 14.48% |
| 2020-09-30 | $1.27B | $0.17B | 13.18% |
| 2020-06-30 | $1.26B | $0.18B | 14.18% |
| 2020-03-31 | $1.26B | $0.18B | 14.56% |
| 2019-12-31 | $1.27B | $0.19B | 14.61% |
| 2019-09-30 | $1.29B | $0.16B | 12.71% |
| 2019-06-30 | $1.31B | $0.13B | 10.00% |
| 2019-03-31 | $1.36B | $0.13B | 9.65% |
| 2018-12-31 | $1.40B | $0.10B | 7.43% |
| 2018-09-30 | $1.43B | $0.16B | 10.92% |
| 2018-06-30 | $1.45B | $0.15B | 10.31% |
| 2018-03-31 | $1.42B | $0.08B | 5.79% |
| 2017-12-31 | $1.29B | $0.05B | 4.18% |
| 2017-09-30 | $1.02B | $0.01B | 0.98% |
| 2017-06-30 | $0.77B | $0.02B | 3.10% |
| 2017-03-31 | $0.54B | $0.07B | 12.83% |
| 2016-12-31 | $0.38B | $0.10B | 27.11% |
| 2016-09-30 | $0.37B | $0.10B | 27.27% |
| 2016-06-30 | $0.36B | $0.10B | 28.37% |
| 2016-03-31 | $0.35B | $0.10B | 28.86% |
| 2015-12-31 | $0.34B | $0.09B | 26.10% |
| 2015-09-30 | $0.33B | $0.09B | 26.59% |
| 2015-06-30 | $0.32B | $0.07B | 22.67% |
| 2015-03-31 | $0.32B | $0.06B | 19.56% |
| 2014-12-31 | $0.31B | $0.06B | 19.42% |
| 2014-09-30 | $0.31B | $0.06B | 20.20% |
| 2014-06-30 | $0.31B | $0.07B | 22.04% |
| 2014-03-31 | $0.31B | $0.07B | 22.68% |
| 2013-12-31 | $0.31B | $0.07B | 23.25% |
| 2013-09-30 | $0.32B | $0.08B | 24.45% |
| 2013-06-30 | $0.32B | $0.08B | 25.24% |
| 2013-03-31 | $0.32B | $0.08B | 26.35% |
| 2012-12-31 | $0.32B | $0.08B | 26.18% |
| 2012-09-30 | $0.31B | $0.09B | 29.03% |
| 2012-06-30 | $0.31B | $0.09B | 27.87% |
| 2012-03-31 | $0.31B | $0.09B | 27.78% |
| 2011-12-31 | $0.30B | $0.09B | 28.24% |
| 2011-09-30 | $0.30B | $0.07B | 24.41% |
| 2011-06-30 | $0.30B | $0.07B | 24.75% |
| 2011-03-31 | $0.29B | $0.07B | 24.48% |
| 2010-12-31 | $0.28B | $0.07B | 22.97% |
| 2010-09-30 | $0.28B | $0.06B | 21.74% |
| 2010-06-30 | $0.25B | $0.05B | 20.87% |
| 2010-03-31 | $0.24B | $0.05B | 21.43% |
| 2009-12-31 | $0.23B | $0.05B | 23.68% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $3.534B | $2.382B |
| ICU Medical, Inc. develops, manufactures and sells innovative medical devices used in vascular therapy, oncology and critical care applications. They are one of the world's leading pure-play infusion therapy companies, with global operations and a wide-ranging product portfolio that includes IV solutions, IV smart pumps, dedicated and non-dedicated IV sets and needlefree connectors, along with pain management and safety software technology designed to help meet clinical, safety and workflow goals. In addition, they manufacture automated pharmacy IV compounding systems with workflow technology, closed systems transfer devices for hazardous IV drugs, and cardiac monitoring systems to optimize patient fluid levels. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $224.526B | 27.00 |
| Boston Scientific (BSX) | United States | $152.309B | 38.13 |
| Stryker (SYK) | United States | $147.916B | 30.93 |
| EssilorLuxottica (ESLOY) | France | $129.703B | 0.00 |
| Medtronic (MDT) | Ireland | $109.157B | 15.94 |
| Lonza Group Ag (LZAGY) | Switzerland | $49.583B | 0.00 |
| Haleon (HLN) | United Kingdom | $47.109B | 26.80 |
| ResMed (RMD) | United States | $36.312B | 27.27 |
| GE HealthCare Technologies (GEHC) | United States | $33.806B | 16.05 |
| Agilent Technologies (A) | United States | $32.907B | 21.74 |
| Terumo (TRUMY) | Japan | $27.953B | 0.00 |
| Koninklijke Philips (PHG) | Netherlands | $22.765B | 16.36 |
| Insulet (PODD) | United States | $22.130B | 86.87 |
| Zimmer Biomet Holdings (ZBH) | United States | $19.288B | 12.39 |
| Baxter (BAX) | United States | $15.985B | 11.94 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $12.381B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $9.032B | 0.00 |
| Demant (WILYY) | Denmark | $8.030B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $7.091B | 23.97 |
| Lantheus Holdings (LNTH) | United States | $5.462B | 13.78 |
| Prestige Consumer Healthcare (PBH) | United States | $4.298B | 19.20 |
| Perrigo (PRGO) | Ireland | $3.605B | 9.14 |
| Haemonetics (HAE) | United States | $3.473B | 15.13 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Envista Holdings (NVST) | United States | $3.154B | 26.21 |
| QuidelOrtho (QDEL) | United States | $2.401B | 16.52 |
| GN Store Nord (GNNDY) | Denmark | $2.164B | 17.92 |
| LeMaitre Vascular (LMAT) | United States | $1.882B | 42.06 |
| AtriCure (ATRC) | United States | $1.558B | 0.00 |
| Neogen (NEOG) | United States | $1.409B | 18.03 |
| AdaptHealth (AHCO) | United States | $1.217B | 12.36 |
| Kestra Medical Technologies (KMTS) | United States | $1.179B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.172B | 26.35 |
| BioLife Solutions (BLFS) | United States | $1.097B | 0.00 |
| InMode (INMD) | Israel | $1.038B | 9.50 |
| Phibro Animal Health (PAHC) | United States | $0.996B | 12.75 |
| Evolus (EOLS) | United States | $0.653B | 0.00 |
| CeriBell (CBLL) | United States | $0.600B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $0.577B | 0.00 |
| Owens & Minor (OMI) | United States | $0.559B | 4.63 |
| Valneva SE (VALN) | France | $0.534B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.524B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.453B | 0.00 |
| Surmodics (SRDX) | United States | $0.398B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.350B | 0.00 |
| SNDL (SNDL) | Canada | $0.347B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.333B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.317B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.312B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.309B | 11.36 |
| Aurora Cannabis (ACB) | Canada | $0.290B | 51.60 |
| Sanuwave Health (SNWV) | United States | $0.285B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.272B | 22.97 |
| Canopy Growth (CGC) | Canada | $0.267B | 0.00 |
| Omeros (OMER) | United States | $0.258B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.255B | 0.00 |
| Cerus (CERS) | United States | $0.250B | 0.00 |
| ZimVie (ZIMV) | United States | $0.248B | 11.28 |
| Biote (BTMD) | United States | $0.214B | 6.02 |
| OraSure Technologies (OSUR) | United States | $0.198B | 0.00 |
| High Tide (HITI) | Canada | $0.186B | 0.00 |
| Brainsway (BWAY) | Israel | $0.185B | 49.05 |
| Quanterix (QTRX) | United States | $0.180B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.180B | 14.47 |
| Organigram Global (OGI) | Canada | $0.166B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.164B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.148B | 18.19 |
| Jin Medical (ZJYL) | China | $0.133B | 0.00 |
| Exagen (XGN) | United States | $0.120B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.116B | 0.00 |
| Agape ATP (ATPC) | $0.101B | 0.00 | |
| MacroGenics (MGNX) | United States | $0.097B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.092B | 0.00 |
| Fonar (FONR) | United States | $0.077B | 10.71 |
| Veru (VERU) | United States | $0.076B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.072B | 0.00 |
| InterCure (INCR) | Israel | $0.070B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.070B | 0.00 |
| Zynex (ZYXI) | United States | $0.066B | 0.00 |
| United Health Products (UEEC) | United States | $0.061B | 0.00 |
| Apyx Medical (APYX) | United States | $0.060B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.054B | 0.00 |
| ImmuCell (ICCC) | United States | $0.045B | 0.00 |
| Modular Medical (MODD) | United States | $0.040B | 0.00 |
| United-Guardian (UG) | United States | $0.037B | 12.94 |
| Rockwell Medical (RMTI) | United States | $0.037B | 0.00 |
| Safety Shot (SHOT) | United States | $0.034B | 0.00 |
| Nephros (NEPH) | United States | $0.023B | 0.00 |
| INLIF (INLF) | $0.020B | 0.00 | |
| Allurion Technologies (ALUR) | United States | $0.018B | 0.00 |
| Flora Growth (FLGC) | United States | $0.014B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.014B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.011B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.010B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.006B | 0.00 |
| Senestech (SNES) | United States | $0.005B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.004B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.003B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| Sharps Technology (STSS) | United States | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |